Simply call 1.800.4HUMIRA (1.800.448.6472) and speak to one of our Insurance Specialists to see if this option is right for you.*Terms and Conditions apply. This benefit covers HUMIRA® (adalimumab) alone or, for rheumatology patients, HUMIRA plus one of the following medications: methotrexate, leflunomide (Arava®), or hydroxychloroquine (Plaquenil®). Eye test required for plaquenil Plaquenil drug assistance program Hydroxychloroquine may cause some people to be agitated, irritable, or display other abnormal behaviors. It may also cause some people to have suicidal thoughts and tendencies, or to become more depressed. If you or your caregiver notice any of these side effects, tell your doctor right away. This medicine may cause hypoglycemia low blood sugar. The patient is eligible for assistance for 12 months. If additional assistance is requested, a new application must be submitted to the hotline. In circumstances of significant financial need and serious medical hardship, individuals, with the help of their doctor, may appeal from denial of participation in this program including denials based. Hydroxychloroquine Plaquenil is considered a disease-modifying anti-rheumatic drug DMARD. It can decrease the pain and swelling of arthritis. It may prevent joint damage and reduce the risk of long-term disability. Hydroxychloroquine is in a class of medications that was first used to prevent and treat malaria. Copay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. Eligibility: Available to patients with commercial prescription insurance coverage for HUMIRA who meet eligibility criteria. Patients assistance for hydroxychloroquine Patient Assistance & Copay Savings Card for HUMIRA® Cost, Sanofi-Aventis Patient Assistance Program - Low body fat and increase risk for chloroquine toxicityTake plaquenil morning or nightEbay plaquenil Hydroxychloroquine HCQ, sold under the brand name Plaquenil among others, is a medication used for the prevention and treatment of certain types of malaria. Specifically it is used for chloroquine-sensitive malaria. Other uses include treatment of rheumatoid arthritis, lupus, and porphyria cutanea tarda. It is taken by mouth. Hydroxychloroquine - Wikipedia. Hydroxychloroquine Plaquenil. In Vitro Antiviral Activity and Projection of Optimized.. Ideal body weight Plaquenil dosing calculations are reprinted with permission from The Lupus Encyclopedia A Comprehensive Guide for Patients and Families, by Donald E. Thomas, published by Johns Hopkins University Press. PLAQUENIL hydroxychloroquine sulfate tablets is indicated for the treatment of rheumatoid arthritis, and discoid and systemic lupus erythematosus, in patients who have not responded satisfactorily to drugs with less potential for serious side effects. Welcome to HealthWell’s Online Application. Before you begin the online application process, please take a moment to review our application instructions below. If you have not yet contacted the manufacturer of your medication to ask about possible assistance through them, we ask that you please do so before you apply to HealthWell for assistance.